DK171379B1 - 1-Acyl-2,3-dihydro-4(1H)-quinolinon-4-oxim-0-sulfonsyrederivater, fremgangsmåder til fremstilling af samme, farmaceutisk sammensætning omfattende samme samt mellemproduktforbindelse til anvendelse ved fremgangsmåden - Google Patents
1-Acyl-2,3-dihydro-4(1H)-quinolinon-4-oxim-0-sulfonsyrederivater, fremgangsmåder til fremstilling af samme, farmaceutisk sammensætning omfattende samme samt mellemproduktforbindelse til anvendelse ved fremgangsmåden Download PDFInfo
- Publication number
- DK171379B1 DK171379B1 DK694487A DK694487A DK171379B1 DK 171379 B1 DK171379 B1 DK 171379B1 DK 694487 A DK694487 A DK 694487A DK 694487 A DK694487 A DK 694487A DK 171379 B1 DK171379 B1 DK 171379B1
- Authority
- DK
- Denmark
- Prior art keywords
- group
- groups
- methyl
- carbon atoms
- dihydro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10284786 | 1986-05-02 | ||
| JP10284786 | 1986-05-02 | ||
| JP62092788A JPS63239270A (ja) | 1986-05-02 | 1987-04-15 | １−アシル−２，３−ジヒドロ−４（１ｈ）−キノリノン−４−オキシム誘導体、その製法、およびそれらを主成分とする利尿、降圧、抗浮腫および腹水除去剤 |
| JP9278887 | 1987-04-15 | ||
| JP8700276 | 1987-05-01 | ||
| PCT/JP1987/000276 WO1987006580A1 (en) | 1986-05-02 | 1987-05-01 | 1-acyl-2,3-dihydro-4(1h)-quinolinone-4-oxime derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK694487D0 DK694487D0 (da) | 1987-12-30 |
| DK694487A DK694487A (da) | 1988-03-02 |
| DK171379B1 true DK171379B1 (da) | 1996-10-07 |
Family
ID=26434165
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK694487A DK171379B1 (da) | 1986-05-02 | 1987-12-30 | 1-Acyl-2,3-dihydro-4(1H)-quinolinon-4-oxim-0-sulfonsyrederivater, fremgangsmåder til fremstilling af samme, farmaceutisk sammensætning omfattende samme samt mellemproduktforbindelse til anvendelse ved fremgangsmåden |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US4839368A (de) |
| EP (1) | EP0243982B1 (de) |
| AU (2) | AU596657B2 (de) |
| CA (1) | CA1314888C (de) |
| DE (1) | DE3769358D1 (de) |
| DK (1) | DK171379B1 (de) |
| ES (1) | ES2036542T3 (de) |
| FI (1) | FI90071C (de) |
| GR (1) | GR3001800T3 (de) |
| HU (1) | HU199803B (de) |
| IE (1) | IE60105B1 (de) |
| IL (1) | IL82399A0 (de) |
| NO (1) | NO174465C (de) |
| NZ (1) | NZ220168A (de) |
| RU (1) | RU1779246C (de) |
| SU (1) | SU1722227A3 (de) |
| WO (1) | WO1987006580A1 (de) |
| ZW (1) | ZW7887A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4839368A (en) * | 1986-05-02 | 1989-06-13 | Mochida Pharmaceutical Co., Ltd. | 1-acyl-2,3-dihydro-4(1H)-quinolinone-4-oxime derivatives |
| JP2602037B2 (ja) * | 1987-10-31 | 1997-04-23 | 持田製薬株式会社 | １−アシル−２，３−ジヒドロ−４（１ｈ）−キノリノン−４−オキシム誘導体、その製法およびそれらを主成分とする利尿、降圧、抗浮腫および腹水除去用医薬組成物 |
| AU661159B2 (en) * | 1992-07-15 | 1995-07-13 | Sumitomo Chemical Company, Limited | N-acyldihydroquinoline derivatives, a method for producing the same and their use as herbicides |
| ES2284741T3 (es) | 1994-06-15 | 2007-11-16 | Otsuka Pharmaceutical Company, Limited | Derivados de benzoheterociclicos utilizados como moduladores de vasoprsinao de oxitocina. |
| HN2000000203A (es) | 1999-11-30 | 2001-06-13 | Pfizer Prod Inc | Procedimiento para la obtencion de 1,2,3,4-tetrahidroquinolinas 4-carboxiamino-2- sustituidas. |
| GB2532990A (en) | 2014-12-05 | 2016-06-08 | Schlumberger Holdings | Corrosion inhibition |
| GB2543498A (en) | 2015-10-19 | 2017-04-26 | Schlumberger Holdings | Corrosion inhibition |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4013662A (en) * | 1974-12-19 | 1977-03-22 | Pfizer Inc. | Alkyl and benzyl 6,7-dialkoxy-2-methyl-4-oxo-1,2,3,4-tetrahydroquinoline-1-carboxylates |
| US3976650A (en) * | 1975-11-04 | 1976-08-24 | Pfizer Inc. | Process for preparing optically active 6,7-dimethoxy-2-methyl-4-oxo-1,2,3,4-tetrahydro-1-quinoline carboxylic acid ester analgesics |
| US4260764A (en) * | 1976-12-22 | 1981-04-07 | Pfizer Inc. | 9-Hydroxyoctahydrobenzo [C] quinolines and intermediates therefor |
| GB2092130B (en) * | 1980-07-28 | 1984-05-10 | Hodogaya Chemical Co Ltd | 4-oximino-1,2,3,4-tetrahydroquinoline derivatives |
| US4421919A (en) * | 1980-07-28 | 1983-12-20 | Hodogaya Chemical Co., Ltd. | 4-Oximino-1,2,3,4-tetrahydroquinoline derivatives |
| GB2081091B (en) * | 1980-07-28 | 1984-03-07 | Mochida Pharm Co Ltd | Hypotensive diuretic pharmaceutical compositions containing tetrahydroquinoline derivatives |
| US4521607A (en) * | 1981-02-27 | 1985-06-04 | Takeda Chemical Industries, Ltd. | Chromanyl glycines |
| CA1189078A (en) * | 1982-07-30 | 1985-06-18 | Hodogaya Chemical Co., Ltd. | Process for producing 4-oximino-1,2,3,4- tetrahydroquinoline derivatives and said derivatives produced thereby |
| DE3416695A1 (de) * | 1984-05-05 | 1985-11-07 | Bayer Ag, 5090 Leverkusen | Amidinohydrazone von tetralin-, chromon-, thiochromon- und tretrahydrochinolin-derivaten, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln |
| PH21213A (en) * | 1984-10-26 | 1987-08-21 | Fujisawa Pharmaceutical Co | Benzene- and pyrazole- fused heterocyclic compound and pharmaceutical composition comprising the same |
| DE3660255D1 (en) * | 1985-04-12 | 1988-07-07 | Ciba Geigy Ag | Oxime sulphonates containing reactive groups |
| US4839368A (en) * | 1986-05-02 | 1989-06-13 | Mochida Pharmaceutical Co., Ltd. | 1-acyl-2,3-dihydro-4(1H)-quinolinone-4-oxime derivatives |
-
1987
- 1987-04-27 US US07/042,784 patent/US4839368A/en not_active Expired - Fee Related
- 1987-04-30 EP EP87106373A patent/EP0243982B1/de not_active Expired - Lifetime
- 1987-04-30 DE DE8787106373T patent/DE3769358D1/de not_active Expired - Fee Related
- 1987-04-30 ES ES198787106373T patent/ES2036542T3/es not_active Expired - Lifetime
- 1987-04-30 ZW ZW78/87A patent/ZW7887A1/xx unknown
- 1987-05-01 CA CA000536174A patent/CA1314888C/en not_active Expired - Fee Related
- 1987-05-01 AU AU72441/87A patent/AU596657B2/en not_active Ceased
- 1987-05-01 NZ NZ220168A patent/NZ220168A/xx unknown
- 1987-05-01 WO PCT/JP1987/000276 patent/WO1987006580A1/en active IP Right Grant
- 1987-05-01 HU HU872931A patent/HU199803B/hu not_active IP Right Cessation
- 1987-05-01 IL IL82399A patent/IL82399A0/xx not_active IP Right Cessation
- 1987-05-11 IE IE115487A patent/IE60105B1/en not_active IP Right Cessation
- 1987-12-30 NO NO875495A patent/NO174465C/no unknown
- 1987-12-30 SU SU874203894A patent/SU1722227A3/ru active
- 1987-12-30 FI FI875771A patent/FI90071C/fi not_active IP Right Cessation
- 1987-12-30 DK DK694487A patent/DK171379B1/da active
-
1988
- 1988-12-23 RU SU884613166A patent/RU1779246C/ru active
-
1989
- 1989-01-25 US US07/301,125 patent/US5077410A/en not_active Expired - Fee Related
-
1990
- 1990-07-02 AU AU58618/90A patent/AU630716B2/en not_active Ceased
-
1991
- 1991-04-18 GR GR91400134T patent/GR3001800T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO875495D0 (no) | 1987-12-30 |
| NO174465B (no) | 1994-01-31 |
| IE60105B1 (en) | 1994-06-01 |
| WO1987006580A1 (en) | 1987-11-05 |
| HU199803B (en) | 1990-03-28 |
| NO875495L (no) | 1988-03-01 |
| AU630716B2 (en) | 1992-11-05 |
| FI875771A (fi) | 1987-12-30 |
| AU7244187A (en) | 1987-11-05 |
| AU596657B2 (en) | 1990-05-10 |
| US4839368A (en) | 1989-06-13 |
| DE3769358D1 (de) | 1991-05-23 |
| GR3001800T3 (en) | 1992-11-23 |
| CA1314888C (en) | 1993-03-23 |
| AU5861890A (en) | 1990-11-15 |
| NO174465C (no) | 1994-05-11 |
| EP0243982A1 (de) | 1987-11-04 |
| ES2036542T3 (es) | 1993-06-01 |
| IE871154L (en) | 1987-11-02 |
| DK694487A (da) | 1988-03-02 |
| FI90071B (fi) | 1993-09-15 |
| DK694487D0 (da) | 1987-12-30 |
| IL82399A0 (en) | 1987-11-30 |
| RU1779246C (ru) | 1992-11-30 |
| SU1722227A3 (ru) | 1992-03-23 |
| US5077410A (en) | 1991-12-31 |
| HUT47912A (en) | 1989-04-28 |
| FI90071C (fi) | 1993-12-27 |
| FI875771A0 (fi) | 1987-12-30 |
| NZ220168A (en) | 1990-02-26 |
| ZW7887A1 (en) | 1987-09-09 |
| EP0243982B1 (de) | 1991-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4705756B2 (ja) | 芳香族アミノ酸誘導体及び医薬組成物 | |
| RU2059627C1 (ru) | Бициклическое гетероциклическое соединение и фармацевтическая композиция | |
| US4879301A (en) | Antiallergic and antiinflammatory benzothiazolinone derivatives | |
| PT98292A (pt) | Processo para a preparacao de heterociclos tioxo e de composicoes farmaceuticas que os contem | |
| EA011719B1 (ru) | Ингибитор высвобождения воспалительного цитокина | |
| US5726325A (en) | Tricyclic compounds | |
| NO323892B1 (no) | Tienotriazolodiazepinforbindelser og medikamenter omfattende disse | |
| JPH05506455A (ja) | ロイコトリエンｄ↓４拮抗剤としてのキノリニル―ベンゾヘテロ二環式誘導体 | |
| NO168303B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocyklyloksoftalazinyl-eddiksyre-derivater | |
| JPH0730054B2 (ja) | 新規カルコン化合物、その製造方法およびこれらの化合物を含有する医薬組成物 | |
| DK171379B1 (da) | 1-Acyl-2,3-dihydro-4(1H)-quinolinon-4-oxim-0-sulfonsyrederivater, fremgangsmåder til fremstilling af samme, farmaceutisk sammensætning omfattende samme samt mellemproduktforbindelse til anvendelse ved fremgangsmåden | |
| JPH01110682A (ja) | 抗アレルギー性活性を有する新規ベンゾチオフエン | |
| JPS609716B2 (ja) | １，２―ベンズインチアゾリン―３―オン類、それらの製造法および医薬としての使用 | |
| KR900006118B1 (ko) | 4-퀴놀론 유도체의 제법 | |
| RU2052458C1 (ru) | Способ получения производных тетразолуксусной кислоты | |
| JPS63225373A (ja) | 新規チアゾリジン−４−オン誘導体およびその酸付加塩 | |
| JPH0692360B2 (ja) | 新規のベンゾセレナゾリノン化合物、これらを調製するプロセスおよびそれらを含む薬剤組成物 | |
| US4968680A (en) | 1-acyl-2,3-dihydro-4(1H)-quinolinone-4-oxime derivatives, process for producing them and use thereof | |
| JPH0647575B2 (ja) | Ｎ―アクリロイルピペラジン誘導体 | |
| JPH01216961A (ja) | １２−リポキシゲネース阻害剤 | |
| CA1333286C (en) | Methods for producing 1-acyl-2,3-dihydro-4(1h)- quinolinone-4-oxime derivatives | |
| JP2003267870A (ja) | 肺高血圧症の予防又は治療剤 | |
| JPH07233072A (ja) | 医薬組成物 | |
| US5194442A (en) | 2,3,4,5-tetrahydro-1-benzoxepins, the use thereof and pharmaceutical products based on these compounds | |
| JP2535528B2 (ja) | 〔２−（１，３−ベンゾジオキソ−ル−５−イル）エチル〕チオ誘導体 |